Join to View Full Profile
St. Jude Children's Research Hospital262 Danny Thomas PlaceMemphis, TN 38105
Dr. Geiger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1994 - 1997
- Yale School of MedicineClass of 1993
Certifications & Licensure
- TN State Medical License 1999 - 2027
- CT State Medical License 1997 - 2000
- American Board of Pathology Clinical Pathology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- GPR65 inactivation in tumor cells drives antigen-independent CAR-T cell resistance via macrophage remodeling.Jayadev Mavuluri, Yogesh Dhungana, Lindsay L Jones, Sheetal Bhatara, Hao Shi
Cancer Discovery. 2025-02-25 - 30 citationsPreferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.Aimee C Talleur, Amr Qudeimat, Jean-Yves Métais, Deanna Langfitt, Ewelina Mamcarz
Blood Advances. 2022-11-08 - 37 citationsRegnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR–T-cell responses against ALLWenting Zheng, Jun Wei, Caitlin C. Zebley, Lindsay L. Jones, Yogesh Dhungana
Blood. 2021-07-15
Journal Articles
- IL-6 Promotes T Cell Proliferation and Expansion Under Inflammatory Conditions in Association with Low-Level RORγt ExpressionTerrence Geiger, MD, The Journal of Immunology
Grant Support
- Treatment Of Autoimmunity With Regulatory T LymphocytesNational Institute Of Allergy And Infectious Diseases2009–2012
- Treatment Of Autoimmunity With Receptor-Modified T CellsNational Institute Of Allergy And Infectious Diseases2004–2008
- Inducing Immune Tolerance With Receptor Modified T CellsNational Institute Of Allergy And Infectious Diseases2001–2003
- Treatment Of EAE Using Genetically Modified CTLNational Institute Of Allergy And Infectious Diseases1999–2001
- Treatment Of EAE Using Genetically Modified CTLNational Institute Of Allergy And Infectious Diseases1997–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: